Farms.com Home   News

CULT Food Science to Commence Trading on the Canadian Securities Exchange on January 17, 2022

Cellular Agriculture Platform Offers Investors Democratized Access to Portfolio Companies that are Advancing the Development of Novel Technologies to Provide a Sustainable, Environmental and Ethical Solution to the Global Factory Farming and Aquaculture Crises

VANCOUVER, BC - CULT Food Science Corp., an innovative investment platform with an exclusive focus on clean, lab-grown food that is advancing the development of novel technologies to provide a sustainable, environmental and ethical solution to the global factory farming and aquaculture crises, is pleased to announce that its common shares have been approved for listing on the Canadian Securities Exchange (the "CSE") and will commence trading on Monday, January 17, 2022, under the stock ticker symbol "CULT". To coincide with its listing on the CSE, CULT has recently updated its website with new information about the Company and its investee businesses, including but not limited to a current investor presentation, which can all be viewed at https://www.cultfoodscience.com/.

Additionally, with the listing on the CSE complete, the Company will be pursuing options for increased liquidity for its shareholders in Europe and the United States. CULT also intends to submit an application to the Depository Trust Company (the "DTC") to have the Company's common shares eligible for delivery and depository services with the DTC to facilitate electronic settlement of transfers of its common shares in the United States. Securities that are eligible to be electronically cleared and settled through the DTC are considered "DTC eligible". This electronic method of clearing securities expedites the receipt of stock and cash, and thus accelerates the settlement process for investors and greatly reduces transaction costs for participating brokerages firms.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.